Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026)

Revolution Medicines' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 63.01% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 63.01% YoY), while the FY2025 annual figure was $24.1 million, up 1286.22% from the prior year.
• Other Non-Current Assets was $4.9 million for Q1 2026 at Revolution Medicines, down from $24.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $31.4 million in Q2 2025 to a low of $851000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $7.7 million across 5 years, with a median of $4.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 75.23% in 2024, then surged 1286.22% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $1.7 million in 2022, then jumped by 304.84% to $7.0 million in 2023, then tumbled by 75.23% to $1.7 million in 2024, then soared by 1286.22% to $24.1 million in 2025, then plunged by 79.88% to $4.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $4.9 million (Q1 2026), $24.1 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.